Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,449,949
-$65,086 QoQ
Shares Held
5,762
-17.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
7.04%
of 13F equity value
Holder Rank
#2,208
of 4,153 holders
Holding Since
Mar 2024
9 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Clayton Financial Group LLC holds $1,737,818 across 2 Drug Manufacturers - General names. ABBV ranks #1 (83.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
5,762 | $1,449,949 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
4,996 | $287,869 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,449,949 | 5,762 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $1,515,035 | 6,966 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,591,661 | 6,966 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $1,429,064 | 6,172 | Shares | Sole | 2025-10-15 | |
| 2025-03-31 | $760,138 | 3,628 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $644,695 | 3,628 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $716,457 | 3,628 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $326,745 | 1,905 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $346,900 | 1,905 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||